X2U93YASupplement Right Atrium with Intraluminal Device, Heterotopic Bioprosthetic Valve(s), Percutaneous Approach, New Technology Group 10
- Billable / Specific Code
X2U93YA is a billable ICD-10-PCS procedure code for Supplement Right Atrium with Intraluminal Device, Heterotopic Bioprosthetic Valve(s), Percutaneous Approach, New Technology Group 10. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRGs 266, 267. The root operation Supplement involves putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | 2 | Cardiovascular System |
| 3 | Operation | U | Supplement |
| 4 | BodyPart | 9 | Atrium, Right |
| 5 | Approach | 3 | Percutaneous |
| 6 | Device/Substance/Technology | Y | Intraluminal Device, Heterotopic Bioprosthetic Valve(s) |
| 7 | Qualifier | A | New Technology Group 10 |
Code History
- 02U638Z — Supplement Right Atrium with Zooplastic, Perc Approach
Similar Procedure Codes
Questions About X2U93YA
Is X2U93YA a billable code?
Yes. X2U93YA is a complete seven-character ICD-10-PCS code, specific enough to report Supplement Right Atrium with Intraluminal Device, Heterotopic Bioprosthetic Valve(s), Percutaneous Approach, New Technology Group 10 on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in X2U93YA mean?
X2U93YA breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character 2 is the Body System (Cardiovascular System); the 3rd character U is the Operation (Supplement); the 4th character 9 is the BodyPart (Atrium, Right); the 5th character 3 is the Approach (Percutaneous); the 6th character Y is the Device/Substance/Technology (Intraluminal Device, Heterotopic Bioprosthetic Valve(s)); the 7th character A is the Qualifier (New Technology Group 10).
What MS-DRG does X2U93YA group to?
On an inpatient stay, Supplement Right Atrium with Intraluminal Device, Heterotopic Bioprosthetic Valve(s), Percutaneous Approach, New Technology Group 10 maps to MS-DRGs 266, 267, with relative weights from 4.7608 to 6.1284. The MS-DRG sets the fixed Medicare payment for the stay.
